Results 1 to 10 of about 985,459 (353)

Changes in Acute-Phase Proteins in Plasma during the Periparturient Period of Dairy Goats [PDF]

open access: yesVeterinary Sciences, 2021
The present study was conducted regarding four acute-phase proteins (APPs) including C-reactive protein (CRP), ceruloplasmin (CP), serum amyloid A (SAA), and haptoglobin (HP) in dairy goats during the periparturient period.
Fangyuan Zeng   +9 more
doaj   +2 more sources

Plasmin activity promotes amyloid deposition in a transgenic model of human transthyretin amyloidosis

open access: yesNature Communications, 2021
ATTR amyloidosis causes heart failure through the accumulation of misfolded transthyretin in cardiac muscle. Here the authors report a mouse model of ATTR amyloidosis and demonstrate the involvement of protease activity in ATTR amyloid deposition.
Ivana Slamova   +18 more
doaj   +1 more source

Clinical Amyloid Typing by Proteomics: Performance Evaluation and Data Sharing between Two Centres

open access: yesMolecules, 2021
Amyloidosis is a relatively rare human disease caused by the deposition of abnormal protein fibres in the extracellular space of various tissues, impairing their normal function. Proteomic analysis of patients’ biopsies, developed by Dogan and colleagues
Diana Canetti   +12 more
doaj   +1 more source

Amyloid Formation by Globular Proteins: The Need to Narrow the Gap Between in Vitro and in Vivo Mechanisms

open access: yesFrontiers in Molecular Biosciences, 2022
The globular to fibrillar transition of proteins represents a key pathogenic event in the development of amyloid diseases. Although systemic amyloidoses share the common characteristic of amyloid deposition in the extracellular matrix, they are ...
Giulia Faravelli   +20 more
doaj   +1 more source

Calcium Binds to Transthyretin with Low Affinity

open access: yesBiomolecules, 2022
The plasma protein transthyretin (TTR), a transporter for thyroid hormones and retinol in plasma and cerebrospinal fluid, is responsible for the second most common type of systemic (ATTR) amyloidosis either in its wild type form or as a result of ...
Cristina Cantarutti   +8 more
doaj   +1 more source

Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage

open access: yesESC Heart Failure, 2020
Aims Cardiac transthyretin amyloidosis (ATTR‐CM) is a progressive and fatal condition. Prognosis can be determined at diagnosis according to the National Amyloidosis Centre (NAC) transthyretin amyloidosis (ATTR) stage.
Steven Law   +14 more
doaj   +1 more source

A prospective study of nutritional status in immunoglobulin light chain amyloidosis

open access: yesHaematologica, 2013
Weight loss is common in systemic immunoglobulin light chain amyloidosis but there are limited data on the impact of nutritional status on outcome.
Prayman T. Sattianayagam   +12 more
doaj   +1 more source

Analysis of Cardiac Amyloidosis Progression Using Model-Based Markers

open access: yesFrontiers in Physiology, 2020
Deposition of amyloid in the heart can lead to cardiac dilation and impair its pumping ability. This ultimately leads to heart failure with worsening symptoms of breathlessness and fatigue due to the progressive loss of elasticity of the myocardium ...
Wenguang Li   +11 more
doaj   +1 more source

Clinical profile and treatment outcome of older (>75 years) patients with systemic AL amyloidosis

open access: yesHaematologica, 2015
Systemic AL amyloidosis, a disease with improving outcomes using novel therapies, is increasingly recognized in the elderly but treatment and outcomes have not been systematically studied in this group of patients in whom comorbidities and frailty may ...
Sajitha Sachchithanantham   +10 more
doaj   +1 more source

Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry

open access: yesScientific Reports, 2021
Hereditary transthyretin-mediated (hATTR) amyloidosis is an underdiagnosed, progressively debilitating disease caused by mutations in the transthyretin (TTR) gene.
Margaret M. Parker   +21 more
doaj   +1 more source

Home - About - Disclaimer - Privacy